Olopatadine hydrochloride ophthalmic solution vehicle

DRUG2 trials

Sponsors

Alcon Research

Conditions

Allergic Conjunctivitis

Phase 1

Safety and Comfort of AL-4943A Ophthalmic Solution

CompletedNCT01326858

Alcon ResearchAllergic Conjunctivitis

Start: 2011-04-30End: 2011-06-30Updated: 2015-03-03

Phase 3

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis

CompletedNCT00331500

Alcon ResearchAllergic Conjunctivitis

Start: 2006-04-18End: 2006-07-27Updated: 2017-08-14